Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 410
5
Diseases
11
Unique genes
0.155
Avg. similarity score
Bartter syndrome
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Bartter syndrome
Gitelman syndrome
obsolete antenatal Bartter syndrome
Bartter disease type 2
Bartter disease type 5
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bartter syndrome | 4 | 4 | 9 |
| Gitelman syndrome | 2 | 2 | 6 |
| obsolete antenatal Bartter syndrome | 2 | 2 | 1 |
| Bartter disease type 2 | 1 | 1 | 1 |
| Bartter disease type 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SLC12A1 | 3 / 5 | Bartter syndrome, Gitelman syndrome, obsolete antenatal Bartter syndrome |
| CASR | 2 / 5 | Bartter syndrome, Gitelman syndrome |
| CLCNKB | 2 / 5 | Bartter syndrome, Gitelman syndrome |
| KCNJ1 | 2 / 5 | Bartter disease type 2, Bartter syndrome |
| MAGED2 | 2 / 5 | Bartter disease type 5, Bartter syndrome |
| SLC12A3 | 2 / 5 | Bartter syndrome, Gitelman syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cation-coupled Chloride cotransporters | Reactome | 2 / 7 | 312× | 1.60e-5 | 4.96e-4 ✓ sig. |
| Stimuli-sensing channels | Reactome | 3 / 79 | 41.5× | 4.35e-5 | 1.14e-3 ✓ sig. |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | Reactome | 1 / 1 | 1,092× | 9.16e-4 | 1.27e-2 ✓ sig. |
| MPS I - Hurler syndrome | Reactome | 1 / 1 | 1,092× | 9.16e-4 | 1.27e-2 ✓ sig. |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | Reactome | 1 / 1 | 1,092× | 9.16e-4 | 1.27e-2 ✓ sig. |
| Defective SLC12A3 causes Gitelman syndrome (GS) | Reactome | 1 / 1 | 1,092× | 9.16e-4 | 1.27e-2 ✓ sig. |
| Potassium transport channels | Reactome | 1 / 3 | 364× | 2.75e-3 | 2.89e-2 ✓ sig. |
| Parathyroid hormone synthesis, secretion and action | KEGG | 2 / 115 | 19.0× | 4.72e-3 | 4.22e-2 ✓ sig. |
| Lysosome | KEGG | 2 / 133 | 16.4× | 6.27e-3 | 5.08e-2 |
| Organic anion transporters | Reactome | 1 / 10 | 109× | 9.12e-3 | 6.50e-2 |
| CS/DS degradation | Reactome | 1 / 14 | 78.0× | 1.28e-2 | 7.89e-2 |
| Metabolism of Angiotensinogen to Angiotensins | Reactome | 1 / 17 | 64.2× | 1.55e-2 | 8.86e-2 |
| Glycosaminoglycan degradation | KEGG | 1 / 19 | 57.5× | 1.73e-2 | 9.50e-2 |
| HS-GAG degradation | Reactome | 1 / 22 | 49.6× | 2.00e-2 | 1.03e-1 |
| Renin-angiotensin system | KEGG | 1 / 23 | 47.5× | 2.09e-2 | 1.05e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| chloride transmembrane transport | GO:1902476 | 6 / 114 | 89.4× | 2.03e-11 | 6.94e-9 ✓ sig. |
| renal sodium ion absorption | GO:0070294 | 4 / 21 | 324× | 3.87e-10 | 9.54e-8 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 6 / 667 | 15.3× | 8.02e-7 | 6.93e-5 ✓ sig. |
| potassium ion import across plasma membrane | GO:1990573 | 3 / 46 | 111× | 2.27e-6 | 1.59e-4 ✓ sig. |
| transmembrane transport | GO:0055085 | 5 / 557 | 15.2× | 9.20e-6 | 4.90e-4 ✓ sig. |
| transepithelial chloride transport | GO:0030321 | 2 / 9 | 378× | 1.13e-5 | 5.73e-4 ✓ sig. |
| chloride transport | GO:0006821 | 3 / 81 | 62.9× | 1.26e-5 | 6.26e-4 ✓ sig. |
| renal absorption | GO:0070293 | 2 / 11 | 309× | 1.73e-5 | 8.00e-4 ✓ sig. |
| chloride ion homeostasis | GO:0055064 | 2 / 13 | 261× | 2.45e-5 | 1.05e-3 ✓ sig. |
| sodium ion homeostasis | GO:0055078 | 2 / 20 | 170× | 5.95e-5 | 2.04e-3 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 4 / 404 | 16.8× | 6.30e-5 | 2.14e-3 ✓ sig. |
| potassium ion homeostasis | GO:0055075 | 2 / 21 | 162× | 6.58e-5 | 2.21e-3 ✓ sig. |
| cell volume homeostasis | GO:0006884 | 2 / 27 | 126× | 1.10e-4 | 3.23e-3 ✓ sig. |
| heparin proteoglycan catabolic process | GO:0030211 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
| sialic acid transport | GO:0015739 | 1 / 1 | 1,699× | 5.89e-4 | 1.07e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bartter syndrome | Gitelman syndrome | 0.333 | 4 | 8.07e-13 | 1.04e-11 ✓ sig. |
| Gitelman syndrome | obsolete antenatal Bartter syndrome | 0.143 | 1 | 3.90e-4 | 8.52e-4 ✓ sig. |
| Bartter disease type 2 | Bartter syndrome | 0.100 | 1 | 5.84e-4 | 1.14e-3 ✓ sig. |
| Bartter disease type 5 | Bartter syndrome | 0.100 | 1 | 5.84e-4 | 1.14e-3 ✓ sig. |
| Bartter syndrome | obsolete antenatal Bartter syndrome | 0.100 | 1 | 5.84e-4 | 1.14e-3 ✓ sig. |